News Headlines Article

Study: Breast cancer drug fights superbugs
San Diego Union-Tribune

Already effective against breast cancer, the drug Tamoxifen has secondary effects that can turbo-charge white blood cells, giving them extra power to chase down, trap and consume antibiotic-resistant bacteria.

These findings from UC San Diego, which appear Tuesday in the journal Nature Communications, suggest that a medication known for stopping the growth of malignant breast tumors might also be a weapon in the fight against so-called superbugs — including methicillin-resistant staphylococcus aureus, or MRSA, which kills more than 11,000 Americans each year, according to the U.S. Centers for Disease Control and Prevention.